OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
<p>Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine – the third-generation calcium channel blocker – are characterized by high lipophilicity and tis...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Столичная издательская компания
2015-09-01
|
| シリーズ: | Рациональная фармакотерапия в кардиологии |
| 主題: | |
| オンライン･アクセス: | http://www.rpcardio.ru/jour/article/view/262 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|